Publications
26
Citations
86
Est. group size
~3
Recurring co-author estimate
Active years
22
Publishing since 2005
This publication record appears to combine at least two distinct areas of work: eye cancer (uveal melanoma) and retinal disease treatment outcomes, and separately, laboratory research on protein aggregation related to Alzheimer's disease, including tau protein behavior and amyloid-forming proteins. Because the topics and methods are so different across these publications, it is unclear whether this reflects one researcher with broad interests or a name shared by multiple individuals in the underlying data. Prospective students should verify directly with the institution which specific research focus and lab this record corresponds to.</br>
Publication output was low and sporadic from 2017-2021, then increased noticeably from 2022 onward, with a marked jump in 2025-2026, though this recent surge coincides with a shift toward methods-focused book chapters rather than original research articles.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Inaccessibility Harms: Exploring the Impact of Inaccessible Campus Organizations on Disabled Students
Purdue Journal of Service-Learning and International Engagement · 2026
- Tracking Tau Oligomer Formation In Vitro
Neuromethods · 2026
- Evaluation of the Kinetics of Tau Fibril Formation
Neuromethods · 2026
- Production of Hyperphosphorylated Tau Using a Baculovirus-Insect Cell System
Neuromethods · 2026
- Tau Transgenic Mice
Neuromethods · 2026
- Expression and Purification of Tau in E. coli Cells
Neuromethods · 2026
- Cell-Based Tau Polymerization Assays
Neuromethods · 2026
- Updates on Tau-Related Drug Targets and Potential Disease-Modifying Therapies for Alzheimer Disease
American Journal Of Pathology · 2025
- The aggregation tendencies of the signal peptide regions of prone and not prone to aggregate proteins
Biochemistry and Biophysics Reports · 2025
- Epigallocatechin-3-Gallate: A potential amyloid Fibril Disaggregator of Serum amyloid A1
Biochemistry and Biophysics Reports · 2025
- Understanding alpha-synuclein aggregation propensity in animals and humans
Biochemistry and Biophysics Reports · 2024
- Diabetes mellitus drug discovery: insights into targeting feline and human amylin with small molecules
Veterinary Quarterly · 2023
- Investigation of serum amyloid a within animal species focusing on the 1-25 amino acid region
Veterinary Quarterly · 2023
- Time-to-First-Treatment and Outcomes in Patients with Wet AMD Referred to Ophthalmology Pre - and During the COVID-19 Pandemic.
PubMed · 2022
- Outcome of an active surveillance programme for patients (pts) with uveal melanoma (UM) after primary curative therapy (PTx): Single institution 10-year experience
Annals of Oncology · 2018
- Neuromethods×6
- Annals of Oncology×3
- Biochemistry and Biophysics Reports×3
- Veterinary Quarterly×2
- American Journal Of Pathology×1
- Colleen M. Cebulla
Medicine · The Ohio State University
- Frederick H. Davidorf
Medicine · The Ohio State University
- Mark W. Reid
Medicine · The Ohio State University
- Mohamed H. Abdel‐Rahman
Medicine · The Ohio State University
- H. Boutrid
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile